Abiopharma

Financial Statements and Related Announcement: Half Yearly Results

Diodes Incorporated Announces Proposed Private Placement of $325 Million of Convertible Senior Notes

Xanadu and University of Alberta Partner to Accelerate Pharmaceutical Discoveries with Quantum Computing

Rocket Lab Corporation Announces Dollar-for-Dollar Replacement At-The-Market Equity Program

Biomea Fusion Announces First Patient Dosed in OPAL Study Evaluating Icovamenib in Combination with Semaglutide in Obesity

NMG présente le bilan du T2 2026 et souligne un trimestre charnière marqué par la transition du développement à l’exécution de la mine Matawinie

Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update

Sagimet Biosciences Receives FDA “Study May Proceed” Letter and IND Clearance for Phase 3 Trial in Acne in Adolescent and Adult Patients

Stratasys Releases Second Quarter 2026 Financial Results

NMG Provides Q2 2026 Update and Highlights a Defining Quarter Shifting From Development to Execution of Its Matawinie Mine